These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22996525)

  • 1. UK technology-boost plan disappoints.
    Bhattacharya A
    Nature; 2012 Sep; 489(7416):347. PubMed ID: 22996525
    [No Abstract]   [Full Text] [Related]  

  • 2. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 4. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges for a champion.
    Nat Nanotechnol; 2007 Mar; 2(3):129. PubMed ID: 18654233
    [No Abstract]   [Full Text] [Related]  

  • 6. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology and financing strategies in the development of life science companies.
    Gertler JP; Hu A; Simon J
    Surgery; 2008 Feb; 143(2):198-205. PubMed ID: 18242336
    [No Abstract]   [Full Text] [Related]  

  • 8. Congress punts on SBIR reauthorization.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1065-6. PubMed ID: 20010562
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 10. Policy: Set research priorities in a time of recession.
    Cunningham P
    Nature; 2013 Oct; 502(7472):433-4. PubMed ID: 24159623
    [No Abstract]   [Full Text] [Related]  

  • 11. A look behind the rapid growth in healthcare IS.
    Dorenfest SI
    Healthc Inform; 1997 Jun; 14(6):SS29-30. PubMed ID: 10168120
    [No Abstract]   [Full Text] [Related]  

  • 12. Basic researchers protest UK budget.
    Brumfiel G; Gilbert N
    Nature; 2009 Apr; 458(7242):1084-5. PubMed ID: 19407758
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment: Academic return.
    Eisenstein M
    Nature; 2016 May; 533(7601):S20-1. PubMed ID: 27144604
    [No Abstract]   [Full Text] [Related]  

  • 14. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public markets show signs of life.
    Mitchell P
    Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181
    [No Abstract]   [Full Text] [Related]  

  • 16. The new world disorder.
    Stires D
    Fortune; 2002 Dec; 146(12):62-4, 68, 70 passim. PubMed ID: 12500480
    [No Abstract]   [Full Text] [Related]  

  • 17. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

  • 18. The industry in Europe: more together than apart.
    Med Device Technol; 2005 Nov; 16(9):32, 34, 36-7. PubMed ID: 16438447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denmark in focus.
    Med Device Technol; 2004; 15(1):74. PubMed ID: 14994640
    [No Abstract]   [Full Text] [Related]  

  • 20. French research wins huge cash boost.
    Butler D
    Nature; 2009 Dec; 462(7275):838. PubMed ID: 20016570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.